EUVIMEDEUVIMED entdecken
Crossref

Standard-Dose Azithromycin in Class III Obese Patients Undergoing Unscheduled Cesarean Delivery

Maeve K Hopkins iD, Surabhi Tewari, Meng Yao, Lydia DeAngelo, Lauren Buckley, Victoria Rogness, Swapna Kollikonda, Oluwatosin Goje

American Journal of Perinatology · 01.05.2024 · 41 (S 01 S 01) · e2645-e2650

DOI: 10.1055/a-2135-7084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.05.2024. Verfasst von Maeve K Hopkins und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Maternal and Fetal Medicine, Obstetrics and Gynecology Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio. Hauptthemen laut MEDLINE: Azithromycin, Cesarean Section, Antibiotic Prophylaxis, Surgical Wound Infection. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Perioperative antibiotic prophylaxis reduces cesarean wound complications. This study investigates whether integration of standard-dose (500 mg) azithromycin prophylaxis reduced wound complications in patients with class III obesity (body mass index [BMI] ≥ 40 kg/m2) undergoing unscheduled cesarean delivery. Study Design Retrospective cohort study of patients with class III obesity undergoing unscheduled cesarean delivery in single hospital system from January 1, 2017, to January 1, 2020. A standard dose (500 mg) of azithromycin was integrated into system order sets in 2018. Medical history and postoperative wound outcomes were compared in pre- and postintegration cohorts. Wound complication was defined as composite of wound seroma, hematoma, superficial or deep infection.

Results

A total of 1,273 patients met inclusion criteria, 303 patients in the preorder set group, and 970 patients in the postorder set group. Demographics were similar between the pre- and postintegration cohorts, including BMI (median: 44.4 kg/m2, p = 0.84) and weight at delivery (mean: 121.2 ± 17.8 kg, p = 0.57). Patients in the postintegration cohort had lower rates of composite postpartum wound complication (7.9 vs. 13.9%, p = 0.002), superficial infection or deep infection/abscess (6.7 vs. 10.2%, p = 0.042), and postpartum readmission or unscheduled visits (18.7 vs. 24.4%, p < 0.029). Rates of chorioamnionitis and endometritis were similar between the pre- and postintegration groups (8.6 vs. 6.9%, p = 0.33, and 1.7 vs. 1.9%, p = 0.81, respectively). Patients in the postintegration cohort had lower risk of postoperative composite wound complication (unadjusted odds ratio [OR]: 0.54, confidence interval [CI]: 0.36–0.80, p = 0.002) and lower rates of wound infection (unadjusted OR: 0.63, 95% CI: 0.40–0.99, p = 0.044). When comparing patients who received azithromycin at delivery and patients who did not, standard-dose azithromycin reduced risk of postoperative wound complication (unadjusted OR: 0.67, 95% CI: 0.46–0.99, p = 0.043).

Conclusion

A standard dose of azithromycin provides adequate perioperative prophylaxis in class III obese patients, decreasing rates of postcesarean wound complications and unscheduled postpartum outpatient visits. Key Points

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AzithromycinCesarean SectionAntibiotic ProphylaxisSurgical Wound InfectionAnti-Bacterial AgentsHumansFemaleRetrospective StudiesAdultPregnancyObesityBody Mass IndexObesity, Morbid

Substanzen

AzithromycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Maternal and Fetal Medicine, Obstetrics and Gynecology Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.
  • Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.
  • Department of Quantitative Health Sciences, Cleveland Clinic, Cleveland, Ohio.
  • Department of Obstetrics and Gynecology, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.
  • Department of Obstetrics and Gynecology and Infectious Disease, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.

ORCID-Profile: Maeve K Hopkins

Zitieren

APA

Hopkins, M. K., Tewari, S., Yao, M., DeAngelo, L., Buckley, L., Rogness, V., Kollikonda, S., & Goje, O. (2024). Standard-Dose Azithromycin in Class III Obese Patients Undergoing Unscheduled Cesarean Delivery. American Journal of Perinatology, 41(S 01 S 01), e2645-e2650. https://doi.org/10.1055/a-2135-7084

Vancouver

Hopkins MK, Tewari S, Yao M, DeAngelo L, Buckley L, Rogness V, et al. Standard-Dose Azithromycin in Class III Obese Patients Undergoing Unscheduled Cesarean Delivery. American Journal of Perinatology. 2024;41(S 01 S 01):e2645-e2650. doi:10.1055/a-2135-7084

BibTeX
@article{Hopkins2024,
  author = {Hopkins, Maeve K and Tewari, Surabhi and Yao, Meng and DeAngelo, Lydia and Buckley, Lauren and Rogness, Victoria and Kollikonda, Swapna and Goje, Oluwatosin},
  title = {Standard-Dose Azithromycin in Class III Obese Patients Undergoing Unscheduled Cesarean Delivery},
  journal = {American Journal of Perinatology},
  year = {2024},
  volume = {41},
  number = {S 01 S 01},
  pages = {e2645--e2650},
  doi = {10.1055/a-2135-7084}
}
Kostenlos starten →